Alex Zhavoronkov (L) and Jeffrey Rothstein (Insilico/Johns Hopkins)
As ALS patients unite around Amylyx, a new paper hints at potential druggable targets
ALS is a debilitating, universally fatal disease. As motor neurons die, patients lose their abilities to walk, cut their own food, swallow and eventually, breathe …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
